Nucleosome repositioning in chronic lymphocytic leukemia

Area of Science:

• Epigenetics and Genomics
• Cancer Biology
• Chromatin Structure

Background:

• Nucleosome positioning is crucial for genome regulation, controlling access to DNA.
• Genome-wide nucleosome occupancy data in cancer, especially chronic lymphocytic leukemia (CLL), is limited.
• Understanding chromatin alterations in CLL is vital for deciphering disease mechanisms.

Purpose of the Study:

• To perform a high-resolution, genome-wide comparison of nucleosome maps in CLL patients versus healthy individuals.
• To investigate changes in nucleosome positioning and their correlation with CLL subtypes and disease progression.
• To explore the potential of nucleosome occupancy as a biomarker for patient stratification and disease monitoring.

Main Methods:

• Genome-wide nucleosome mapping at single-base-pair resolution.
• Comparison of nucleosome occupancy, nucleosome repeat length (NRL), and DNA methylation between CLL patients and controls.
• Principal Component Analysis (PCA) of nucleosome occupancy data for sample classification.

Main Results:

• Significant alterations in nucleosome positioning were observed in CLL, including a globally shortened NRL.
• The shortened NRL was more pronounced in the aggressive IGHV-unmutated CLL subtype compared to the IGHV-mutated subtype.
• Changes in nucleosome occupancy correlated with chromatin remodeling, reduced DNA methylation, altered transcription factor binding (including CTCF), and immune response pathways.
• Nucleosome occupancy patterns effectively classified CLL subtypes and distinguished them from normal controls, outperforming DNA methylation and gene expression data.
• PCA of nucleosome occupancy enabled accurate stratification of patients into CLL subtypes.

Conclusions:

• Nucleosome positioning is significantly altered in CLL and serves as a sensitive indicator of epigenetic deregulation.
• Differential nucleosome occupancy provides a novel and powerful readout for dissecting CLL pathogenesis and stratifying patients.
• Changes in nucleosome positioning, particularly NRL, may be applicable for liquid biopsy in patient stratification and disease monitoring.